| 1 |
29448961 | Nuclear receptor agonist-driven modification of inflammation and amyloid pathology enhances and sustains cognitive improvements in a mouse model of Alzheimer's disease. | 2018 Feb 15 |
1 |
| 2 |
26175148 | ABCA1 is Necessary for Bexarotene-Mediated Clearance of Soluble Amyloid Beta from the Hippocampus of APP/PS1 Mice. | 2016 Mar |
1 |
| 3 |
26071899 | RNA-sequencing reveals transcriptional up-regulation of Trem2 in response to bexarotene treatment. | 2015 Oct |
1 |
| 4 |
23764200 | Treatment with bexarotene, a compound that increases apolipoprotein-E, provides no cognitive benefit in mutant APP/PS1 mice. | 2013 Jun 13 |
1 |
| 5 |
24229456 | When the dust settles: what did we learn from the bexarotene discussion? | 2013 |
1 |